medigraphic.com
ISSN 1405-8871 (Print)

2026, Number 1

<< Back Next >>

Aten Fam 2026; 33 (1)

P300 and Cognitive Impairment in Major Depression: A Narrative Review of Its Diagnostic and Prognostic Value

Hernández-Chávez A, Martínez-Zarraluqui A, Rivero-López CA, Sánchez-Martínez AA, Sampieri-Cabrera R, Staufert-Solis F, Guízar-Sánchez D

Language: Spanish
References: 37
Page: 54-61
PDF size: 188.61 Kb.


ABSTRACT

Objective: To analyze the potential diagnostic and prognostic biomarker value of P300 parameters (amplitude and latency) in cognitive symptoms of major depressive disorder (MDD). Methods: A literature search was conducted in Web of Science and PubMed, covering publications from 2019 to 2025. The search terms used were P300, parameters, cognitive impairment, and major depressive disorder. An initial screening identified 89 articles. Selection criteria included original articles with available references, peer-reviewed publications, and studies providing updated information on diagnosis and treatment with relevant contributions to this search. After applying these criteria, 28 articles were included. Results: Patients with major depressive disorder showed prolonged P300 latency compared with healthy controls. These alterations may reflect different aspects of cognitive dysfunction, such as attention, processing speed, and working memory. Conclusion: As an objective and noninvasive tool, P300 is useful for assessing cognitive function; however, further research is needed to validate its use as a diagnostic and prognostic biomarker.


REFERENCES

  1. Bains N, Abdijadid S. Major Depressive Disorder.En: StatPearls Treasure Island (FL): Stat-Pearls Publishing; 2025 [Internet]. [citado 2025oct 3]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK559078/

  2. Malhi GS, Mann JJ. Depression. Lancet.2018;392(10161):2299–2312.

  3. Ahern E, Semkovska M. Cognitive functioningin the first-episode of major depressive disorder:A systematic review and meta-analysis. Neuropsychology.2017;31(1):52–72.

  4. Kriesche D, Woll CFJ, Tschentscher N, EngelRR, Karch S. Neurocognitive deficits in depression:a systematic review of cognitive impairmentin the acute and remitted state. Eur Arch PsychiatryClin Neurosci. 2023;273(5):1105–1128.

  5. Rhee TG, Shim SR, Manning KJ, Tennen HA,Kaster TS, d’Andrea G, et al. Neuropsychologicalassessments of cognitive impairment in majordepressive disorder: a systematic review andmeta-analysis with meta-regression. PsychotherPsychosom. 2024;93(1):8–23.

  6. Semkovska M, Quinlivan L, O’Grady T, JohnsonR, Collins A, O’Connor J, et al. Cognitivefunction following a major depressive episode:a systematic review and meta-analysis. LancetPsychiatry. 2019;6(10):851–861.

  7. Schwert C, Stohrer M, Aschenbrenner S, WeisbrodM, Schröder A. Neurocognitive profile ofoutpatients with unipolar depressive disorders. JClin Exp Neuropsychol. 2019;41(9):913–924.

  8. Subhas N, Ang JK, Tan KA, Ahmad SNA. Relationsbetween clinical characteristics and cognitivedeficits among adult patients diagnosed withmajor depressive disorder. Int J Psychiatry ClinPract. 2023;27(3):219–231.

  9. Zygouris NC. Differences in children and adolescentswith depression before and after a remediationprogram: an event-related potentialstudy. Brain Sci. 2024;14(7):660.

  10. Czerwińska A, Pawłowski T. Cognitive dysfunctionsin depression – significance, descriptionand treatment prospects. Psychiatr Pol.2020;54(3):453–66.

  11. Demirayak P, Kıyı İ, İşbitiren YÖ, Yener G.Cognitive load associates prolonged P300 latencyduring target stimulus processing in individualswith mild cognitive impairment. Sci Rep.2023;13(1):15956.

  12. Jiang M. Serum BDNF and P300 latency: potentialmarkers of mild cognitive impairment indepressed patients [Letter]. Neuropsychiatr DisTreat. 2024;20:1395–1396.

  13. Xue Z, Zhu X, Wu W, Zhu Y, Xu Y, Yu M.Synapse-related serum and P300 biomarkerspredict the occurrence of mild cognitive impairmentin depression. Neuropsychiatr Dis Treat.2024;20:493–503.

  14. Huang WJ, Chen WW, Zhang X. The neurophysiologyof P300—an integrated review. Eur RevMed Pharmacol Sci. 2015;19(8):1480–8.

  15. Beńo-Ruiz de la Sierra RM, Fernández-LinsenbarthI, Roig-Herrero A, Díez-Revuelta Á.Electroencephalography for the study of the auditoryP300 evoked potential and derived measurements.En: Urigüen L, Díez-Alarcia R. (eds.)Schizophrenia. Methods in Molecular Biology,2687. Humana, New York, NY. : Springer US;2023. p. 93–106.

  16. Helfrich RF, Knight RT. Cognitive neurophysiology:event-related potentials. En: Handbookof Clinical Neurolygy, 160 Elsevier; 2019. p.543–58. [citado 14 may 2025]. Disponibleen: https://linkinghub.elsevier.com/retrieve/pii/B9780444640321000369

  17. Idiazabal MA, Palau M, Fernández E, Fierro G.Estudios neurofisiológicos en los trastornos delneurodesarrollo: potenciales evocados cognitivos.Medicina (B. Aires). 2023;83(Supl 2):12–16.

  18. Kool L, Oranje B, Meijs H, De Wilde B, VanHecke J, Niemegeers P, et al. Event-related potentialsand use of psychotropic medicationin major psychiatric disorders. Psychiatry Res.2022;314:114637.

  19. Arıkan MK, İlhan R, Orhan Ö, Esmeray MT,Turan Ş, Gica Ş, et al. P300 parameters in majordepressive disorder: a systematic reviewand meta-analysis. World J Biol Psychiatry.

  20. 2024;25(4):255–266.20. Zhou AY, Panagioti M, Esmail A, Agius R, VanTongeren M, Bower P. Factors associated withburnout and stress in trainee physicians: a systematicreview and meta-analysis. JAMA NetwOpen. 2020;3(8):e2013761.

  21. Cai N, Gaohua W, Xiaoping W, Zhongchun L,Huiling W, Ling X, et al. Analysis of ERP andP300 characteristics and brain network connectivityin first-episode depression. Chin J BehavMed Brain Sci. 2015;24:326–8. No encontréesta referencia

  22. Santopetro NJ, Brush CJ, Bruchnak A, KlawohnJ, Hajcak G. A reduced P300 prospectivelypredicts increased depressive severity in adultswith clinical depression. Psychophysiology.2021;58(4):e13767.

  23. Santopetro NJ, Amir N, Nelson BD, Klein DN,Hajcak G. Attenuated Doors‐Locked P300 amplitudeand elevated depressive symptoms: effectsof age and sex in two independent samples ofyouth. Psychophysiology. 2025;62(2):e70009.

  24. Santopetro NJ, Barch D, Luby JL, Hennefield L,Gilbert KE, Whalen DJ, et al. Deficits in DoorsP300 amplitude during adolescence associatedwith preschool‐onset depression. Psychophysiology.2023;60(10):e14331.

  25. Moretta T, Messerotti Benvenuti S. Familial riskfor depression is associated with reduced P300and late positive potential to affective stimuli andprolonged cardiac deceleration to unpleasant stimuli.Sci Rep. 2023;13(1):6432.

  26. Zhao L, Zhou D, He X, Peng X, Hu J, Ma L,et al. Changes in P300 amplitude to negativeemotional stimuli correlate with treatment responsivenessto sertraline in adolescents with depression.Brain Res. 2024;1845:149272.

  27. Mann E, Ren X, Wilhelm R, McNaughton B,Bethel D, Rojas L, et al. Baseline P300 amplitudeduring stop-signal task predicts major depressionsymptoms after 12 months. BiologicalPsychiatry. 2023;93(9):S154–5.

  28. Zhou L, Wang G, Nan C, Wang H, Liu Z,Bai H. Abnormalities in P300 components indepression: an ERP-sLORETA study. Nord JPsychiatry. 2019;73(1):1–8.

  29. Tripathi SM, Mishra N, Tripathi RK, GurnaniKC. P300 latency as an indicator of severityin major depressive disorder. Ind Psychiatry J.2015;24(2):163-167.

  30. Liu H, Wen Y, Liang X, Xu Y, Qiao D, YangC, et al. Prefrontal cortex neural activity predictsreduction of non-suicidal self-injury inadolescents with major depressive disorder: anevent-related potential study. Front Neurosci.2022;16:972870.

  31. Yan D, Ren Y, Wu K, Zhou Z, Jia J, Liu X, etal. The comparison of cognitive potential P300in major depressive disorder between with andwithout family history. Chin J Behav Med BrainSci. 2012;(12):699–701.

  32. Cao P, Tan J, Liao X, Wang J, Chen L, Fang Z,et al. Standardized treatment and shortened depressioncourse can reduce cognitive impairmentin adolescents with depression. J Korean AcadChild Adolesc Psychiatry. 2024;35(1):90–97.

  33. Wu X, Lin P, Yang J, Song H, Yang R, Yang J.Dysfunction of the cingulo-opercular networkin first-episode medication-naive patients withmajor depressive disorder. J Affect Disord.2016;200:275–83.

  34. Hu B, Rao J, Li X, Cao T, Li J, Majoe D, et al.Emotion regulating attentional control abnormalitiesin major depressive disorder: an event-relatedpotential study. Sci Rep. 2017;7(1):13530.

  35. Deveney CM, Pizzagalli DA. The cognitive consequencesof emotion regulation: an ERP investigation.Psychophysiology. 2008;45(3):435–44.

  36. Wang Y, Li C, Liu X, Peng D, Wu Y, Fang Y.P300 event-related potentials in patients withdifferent subtypes of depressive disorders. FrontPsychiatry [Internet]. 2023;13:1021365.

  37. Key AP, Thornton-Wells TA, Smith DG. Electrophysiologicalbiomarkers and age characterizephenotypic heterogeneity among individualswith major depressive disorder. Front Hum Neurosci.2023;16:1055685.




2020     |     www.medigraphic.com